Back

Structural Basis of Serine Protease Inhibition by Antibodies from Biased Fab Phage-Display Libraries

Anderson, K. J.; Lee, M. S.; Sevillano, N.; Chen, G.; Hornsby, M. J.; Sidhu, S. S.; Craik, C. S.

2026-03-14 molecular biology
10.64898/2026.03.12.711446 bioRxiv
Show abstract

Biased Fab phage-display libraries were designed to determine whether inhibitory CDR H3 motifs from potent anti-matriptase antibodies could be transferred to target homologous serine proteases. Using reverse-binding and substrate-like H3 motifs from parental clones A11 and E2 as templates, six synthetic libraries with 1010 diversity were constructed. Selection against matriptase identified sixteen inhibitors with sub-100 nM potency, representing 100,000-fold improvement over circularized H3 loops alone. Selection against TMPRSS2, a serine protease implicated in viral entry and prostate cancer with 43% sequence identity to matriptase, yielded binders with micromolar inhibitory potency. Selection against urokinase plasminogen activator (uPA, 35% identity) identified binders that adopted a substrate-like CDR H3 binding mode in our structural models. Across all reference structures, including the separately identified uPA inhibitor AB2 (PDB: 9PYF, deposited with this work), benchmarking of five co-folding methods and rigid-body docking showed that co-folding consistently achieved acceptable to high quality DockQ scores, outperforming traditional docking and capturing the recognition of key active site determinants. Ensemble predictions of mutational binding energy changes ({Delta}{Delta}G) using these models identified key paratope-epitope interactions, with predictions validated through mutagenesis. This work establishes a framework integrating biased antibody libraries with computational structure prediction and analysis for targeting conserved protease epitopes.

Matching journals

The top 13 journals account for 50% of the predicted probability mass.

1
Journal of Chemical Information and Modeling
207 papers in training set
Top 0.7%
8.5%
2
Antibody Therapeutics
16 papers in training set
Top 0.1%
4.9%
3
Journal of Medicinal Chemistry
68 papers in training set
Top 0.2%
4.9%
4
Nature Communications
4913 papers in training set
Top 35%
4.3%
5
ChemMedChem
15 papers in training set
Top 0.1%
4.0%
6
Scientific Reports
3102 papers in training set
Top 36%
3.6%
7
eLife
5422 papers in training set
Top 25%
3.6%
8
Cell Reports
1338 papers in training set
Top 14%
3.6%
9
Advanced Science
249 papers in training set
Top 5%
3.6%
10
Viruses
318 papers in training set
Top 2%
3.1%
11
mAbs
28 papers in training set
Top 0.1%
2.7%
12
PLOS ONE
4510 papers in training set
Top 45%
2.6%
13
PLOS Computational Biology
1633 papers in training set
Top 13%
2.1%
50% of probability mass above
14
Molecular Therapy
71 papers in training set
Top 1%
1.9%
15
Protein Science
221 papers in training set
Top 0.7%
1.9%
16
Computational and Structural Biotechnology Journal
216 papers in training set
Top 4%
1.9%
17
Structure
175 papers in training set
Top 2%
1.7%
18
Proceedings of the National Academy of Sciences
2130 papers in training set
Top 32%
1.7%
19
Frontiers in Immunology
586 papers in training set
Top 4%
1.7%
20
Journal of Molecular Biology
217 papers in training set
Top 2%
1.7%
21
Journal of Biological Chemistry
641 papers in training set
Top 2%
1.5%
22
International Journal of Biological Macromolecules
65 papers in training set
Top 2%
1.5%
23
Journal of the American Chemical Society
199 papers in training set
Top 3%
1.5%
24
Communications Biology
886 papers in training set
Top 12%
1.3%
25
JACS Au
35 papers in training set
Top 0.6%
1.3%
26
ACS Omega
90 papers in training set
Top 3%
1.2%
27
Acta Pharmaceutica Sinica B
11 papers in training set
Top 0.6%
1.1%
28
ACS Chemical Biology
150 papers in training set
Top 2%
0.9%
29
Journal of Thrombosis and Haemostasis
28 papers in training set
Top 0.6%
0.9%
30
ACS Central Science
66 papers in training set
Top 2%
0.8%